93 related articles for article (PubMed ID: 21419045)
1. [The effect of CTLA4-Ig gene modified dendritic cell on Th1/Th2 balance in vitro].
Ying LY; Fu Z; Luo J; Chen Y; Liu EM; Wang LJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):266-9. PubMed ID: 21419045
[TBL] [Abstract][Full Text] [Related]
2. CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.
Yang DF; Qiu WH; Zhu HF; Lei P; Wen X; Dai H; Zhou W; Shen GX
Transpl Immunol; 2008 Jul; 19(3-4):197-201. PubMed ID: 18667318
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells prime the responsiveness of autologous CD4+ T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction.
Newland A; Russ G; Krishnan R
Immunology; 2006 Jun; 118(2):216-23. PubMed ID: 16771856
[TBL] [Abstract][Full Text] [Related]
4. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
5. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY
J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867
[TBL] [Abstract][Full Text] [Related]
6. DCs sensitized with mPD-L1-Ig fusion protein improve the effect of heart transplantation in mice by promoting the generation of T-reg cells.
Liu C; Chen H; Jia J; Hong T; Wang C
Cell Immunol; 2014 Jul; 290(1):169-77. PubMed ID: 24997656
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte antigen 4 immunoglobulin modified dendritic cells attenuate allergic airway inflammation and hyperresponsiveness by regulating the development of T helper type 1 (Th1)/Th2 and Th2/regulatory T cell subsets in a murine model of asthma.
Ying L; Fu Z; Luo J; Zhou C; Chen Y; Wang L; Liu E
Clin Exp Immunol; 2011 Jul; 165(1):130-9. PubMed ID: 21545583
[TBL] [Abstract][Full Text] [Related]
8. CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk.
Mayer E; Hölzl M; Ahmadi S; Dillinger B; Pilat N; Fuchs D; Wekerle T; Heitger A
Int Immunopharmacol; 2013 Mar; 15(3):638-45. PubMed ID: 23434857
[TBL] [Abstract][Full Text] [Related]
9. CTLA4-Ig preserves thymus-derived T regulatory cells.
Ahmadi SM; Hölzl MA; Mayer E; Wekerle T; Heitger A
Transplantation; 2014 Dec; 98(11):1158-64. PubMed ID: 25269023
[TBL] [Abstract][Full Text] [Related]
10. Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3.
Kowalczyk A; D'Souza CA; Zhang L
Eur J Immunol; 2014 Apr; 44(4):1143-55. PubMed ID: 24338929
[TBL] [Abstract][Full Text] [Related]
11. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
12. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
He SB; Sun K; Wang L; Li DC; Zhang YY
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
[TBL] [Abstract][Full Text] [Related]
13. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
14. CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression.
Cutolo M; Montagna P; Soldano S; Contini P; Paolino S; Pizzorni C; Seriolo B; Sulli A; Brizzolara R
Clin Exp Rheumatol; 2015; 33(2):250-4. PubMed ID: 25896473
[TBL] [Abstract][Full Text] [Related]
15. Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10.
Janelidze S; Enell K; Visse E; Darabi A; Salford LG; Siesjö P
Immunol Lett; 2005 Nov; 101(2):193-201. PubMed ID: 16002150
[TBL] [Abstract][Full Text] [Related]
16. [Bioimmunological characteristics of mature or immature murine dendritic cells].
Wang KL; Guo L; Shi RF; Wang JL; Dong SH
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(45):3225-8. PubMed ID: 22333110
[TBL] [Abstract][Full Text] [Related]
17. T lymphocyte antigen 4-modified dendritic cell therapy for asthmatic mice guided by the CCR7 chemokine receptor.
Chen Y; Wang Y; Fu Z
Int J Mol Sci; 2014 Aug; 15(9):15304-19. PubMed ID: 25177863
[TBL] [Abstract][Full Text] [Related]
18. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival.
O'Rourke RW; Kang SM; Lower JA; Feng S; Ascher NL; Baekkeskov S; Stock PG
Transplantation; 2000 Apr; 69(7):1440-6. PubMed ID: 10798768
[TBL] [Abstract][Full Text] [Related]
19. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
[TBL] [Abstract][Full Text] [Related]
20. Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses.
Gao D; Mondal TK; Lawrence DA
Toxicol Appl Pharmacol; 2007 Jul; 222(1):69-79. PubMed ID: 17512567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
